ANIXA BIOSCIENCES, INC. Amortization of Debt Discount (Premium)
ANIXA BIOSCIENCES, INC. (ANIX) reported Amortization of Debt Discount (Premium) of $634.27 thousand for the 12-month period ending 2014-10-31, per its 10-K filed 2015-12-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2015-12-23
- ANIXA BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2014-10-31 was $59.06K, a 39.76% decline year-over-year.
- ANIXA BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2014-07-31 was $128.65K, a 44.06% decline year-over-year.
- ANIXA BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2014-04-30 was $229.25K, a 71.20% decline year-over-year.
- ANIXA BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2014-01-31 was $217.32K, a 4052.01% increase year-over-year.
- ANIXA BIOSCIENCES, INC. amortization of debt discount (premium) for fiscal 2014 was $634.27K, a 36.01% decline from fiscal 2013.
- ANIXA BIOSCIENCES, INC. amortization of debt discount (premium) for fiscal 2013 was $991.18K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2014-10-31 | $59.06K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $187.70K derived: sum of 2 quarters · filed 2015-12-23 | $416.95K derived: sum of 3 quarters · filed 2015-12-23 | $634.27K 10-K · filed 2015-12-23 |
| 2014-07-31 | $128.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $357.89K derived: sum of 2 quarters · filed 2015-08-18 | $575.21K 10-Q · filed 2015-08-18 | $673.24K derived: sum of 4 quarters · filed 2015-08-18 |
| 2014-04-30 | $229.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $446.56K 10-Q · filed 2015-05-22 | $544.60K derived: sum of 3 quarters · filed 2015-05-22 | $774.56K derived: sum of 4 quarters · filed 2015-05-22 |
| 2014-01-31 | $217.32K 10-Q · filed 2015-03-09 | $315.35K derived: sum of 2 quarters · filed 2015-03-09 | $545.31K derived: sum of 3 quarters · filed 2015-03-09 | $1.34M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-10-31 | $98.03K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $328.00K derived: sum of 2 quarters · filed 2015-01-29 | $1.12M derived: sum of 3 quarters · filed 2015-01-29 | $991.18K 10-K · filed 2015-01-29 |
| 2013-07-31 | $229.96K 10-Q/A · filed 2013-09-20 | $1.03M derived: sum of 2 quarters · filed 2014-06-16 | $893.15K 10-Q · filed 2014-09-15 | |
| 2013-04-30 | $795.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | $801.13K 10-Q · filed 2014-06-16 | ||
| 2013-01-31 | $5.23K 10-Q · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |